Special Issue "Nano-Biotechnology: Nanomaterials for Targeted Delivery"
A special issue of Crystals (ISSN 2073-4352).
Deadline for manuscript submissions: closed (25 February 2022) | Viewed by 7586
Interests: nanomedicine; DNA nanocarriers; aptamer; remote control; gene activation; biomimics
2. Cardiology Department, Emergency Clinical County Hospital, Iasi, Romania
Interests: cardiac arrhythmias; pacemakers; heart rate variability; electrocardiography; cardiovascular pharmacology; experimental medicine; blood pressure; heart failure; hypertension; acute coronary syndromes
Special Issues, Collections and Topics in MDPI journals
We now have potential platforms for improving lives by introducing non-aggressive methods of therapy and reducing the side effects of medical agents. This has already begun through the targeted delivery of therapeutics and remote control of bioprocesses. Nanobiotechnology can develop materials with unique properties for this purpose such as a high level of penetration, high capacity for loading cargo and multi-functionality. There are some nanomaterials that are approved by the Food, Drug Administration (FDA) and European Medicines Agency (EMA), which are mostly biomimicking nanocarriers such as lipid and peptide nanoparticles but also some metal nanoparticles such as SPOIN, and nanocrystals such as paliperidone palmitate and dantrolene sodium have FDA and EMA approval. Researchers have made substantial efforts to produce systems for delivering therapeutics at specific sites at the desired times with controlled doses using nanomaterials. However, there have been few clinical applications, and this important issue should be addressed in our future studies. The change in the identity of nanocarriers should also be researched; this results in a change in their fate in the body due to corona formation on the nanoparticle’s surface. To discuss this and many other open questions, introduce the latest research and develop new ideas and directions, we will provide a Special Issue on Nanomaterials and Targeted delivery in Crystals, an open access journal.
This Special Issue is collecting research articles and review papers on “Nanobiotechnology: Nanomaterials for Targeted Delivery”.
Dr. Fahimeh Charbgoo
Dr. Ionut Tudorancea
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Crystals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Drug targeting
- Remote control
- Trigger-responsive system